How Tony Robbins Became An Investor In Celularity

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

You probably know Tony Robbins as one of the world’s leading life coaches. But did you know that when he was a junior in high school, he experienced a ten-inch growth spurt? However, it wasn’t until he was in his early 30s that he learned the cause. Acromegaly, a rare hormone disorder, develops when a person’s pituitary gland produces too much growth hormone. When this happens, bones increase in size, including hands, feet, and face. Later in life, it can lead to degenerative joint disease. “Tony Robbins is an incredibly physically active guy, basically a professional athlete, but he had been facing some real challenges, bad knees, bad shoulders, bad hips and all that,” relates Robert Hariri, M.D., Ph.D., cofounder and CEO of Celularity and subject of an upcoming feature in Life Science Leader magazine. Hariri says he and Robbins became close personal friends during this challenging period as he educated him on the potential of cell therapy. “I told he him that cell therapy treatments were still under development and not approved in the U.S., but that there were other places in the world where he could access them.”  According to Hariri, Robbins went overseas to get cell therapy treatments, and found the experience so life altering that he has almost become evangelical about what it can do. “That’s one of the reasons why he became an investor in Celularity,” Hariri contends.